IFWM
TEVA icon

Institute for Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Institute for Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.66K Buy
+108
New +$3.6K ﹤0.01% 1505
2022
Q3 		– Sell
-38,940
Closed -$293K – 520
2022
Q2 		$293K Buy
38,940
+9,900
+34% +$86.3K 0.06% 398
2022
Q1 		$273K Buy
+29,040
New +$242K 0.04% 451
2019
Q2 		– Sell
-1,140
Closed -$18K – 494
2019
Q1 		$18K Buy
+1,140
New +$20.1K ﹤0.01% 447

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Institute for Wealth Management's TEVA Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 108 shares worth $3.66K. The stake represents ﹤0.01% of the portfolio and ranks #1505 among its holdings. This is a return to the name: Institute for Wealth Management previously reported a position in TEVA as recently as Q2 2022.

Institute for Wealth Management first reported a position in TEVA in Q1 2019 and has held it in 4 quarters since. The position peaked at $293K in Q2 2022. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Institute for Wealth Management held 108 shares of Teva Pharmaceutical Industries Limited worth $3.66K as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new Institute for Wealth Management position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #1505 holding.
  • Institute for Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2019 and has held it in 4 quarters since.
  • Institute for Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $293K in Q2 2022.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.